Genesis Healthcare, Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2016. For the quarter, the company's net revenues were $1,402.860 million against $1,440.721 million a year ago. Income before income tax expense (benefit) was $43.589 million against $113.675 million a year ago. Income from continuing operations was $41.286 million against loss of $312.992 million a year ago. Net income attributable to the company was $22.457 million against net loss of $426.195 million a year ago. EBITDAR was $271.365 million against $116.715 million a year ago. EBITDA was $234.917 million against $79.472 million a year ago. Adjusted EBITDAR was $156.648 million against $161.031 million a year ago. Adjusted EBITDA was $33.196 million against $39.682 million a year ago.

For the year, the company's net revenues were $5,732.430 million against $5,619.224 million a year ago. Loss before income tax expense (benefit) was $135.513 million against $353.025 million a year ago. Loss from continuing operations was $118.078 million against $525.549 million a year ago. Net loss attributable to the company was $64.013 million against $426.195 million a year ago. Net cash provided by operating activities was $68.361 million against $8.618 million a year ago. EBITDAR was $793.734 million against $542.677 million a year ago. EBITDA was $647.490 million against $392.401 million a year ago. Adjusted EBITDAR was $696.489 million against $725.588 million a year ago. Adjusted EBITDA was $197.460 million against $243.870 million a year ago.

For the quarter, long-lived asset impairment was $35.431 million against $28.546 million a year ago.

For the full year 2017, the company expects revenues to be in the range of $5,400.0 million to $5,500.0 million, EBITDA to be in the range of $503.0 million to $519.0 million, adjusted EBITDA to be in the range of $542.0 million to $558.0 million, adjusted EBITDAR to be in the range of $675.0 million to $710.0 million.